首页> 外文学位 >Adipsin Is an ERα Target Gene that Leads to Endocrine Resistance in Breast Cancer with ESR1 Mutations

【24h】

Adipsin Is an ERα Target Gene that Leads to Endocrine Resistance in Breast Cancer with ESR1 Mutations

机译：Adipsin是一种ERα靶基因，导致ESR1突变的乳腺癌内分泌抵抗力

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Malone, Marie Kathryn.;
展开▼
作者单位

Albany College of Pharmacy and Health Sciences.;

展开▼
授予单位 Albany College of Pharmacy and Health Sciences.;
学科
学位 M.S.
年度 2020
页码 48 p.
总页数 48
原文格式 PDF
正文语种 eng
中图分类 AAI28028385;
关键词

相似文献

外文文献
中文文献
专利

1. ESR1 mutations are not a mechanism of primary resistance to aromatase inhibitors in ER-positive breast cancer treated with neoadjuvant endocrine therapy [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：ESR1突变不是用Neoadjuvant内分泌治疗治疗的ER阳性乳腺癌中芳香酶抑制剂的常规抗性的机制
2. Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance [J] . Lesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, Nature Communications . 2017,第1期

机译：在模拟内分泌抵抗力的乳腺癌细胞系中发现自然发生的ESR1突变
3. Evolving Role of the Estrogen Receptor as a Predictive Biomarker: ESR1 Mutational Status and Endocrine Resistance in Breast Cancer [J] . Lauring Josh, Wolff Antonio C. Journal of Clinical Oncology . 2016,第25期

机译：雌激素受体作为预测性生物标志物的进化作用：乳腺癌中的ESR1突变状态和内分泌抵抗力
4. A Single Tube Screening of Endocrine Therapy Resistance ESR1 Mutations in ER-Positive Breast Cancer [C] . Akihiro Tsuyada, Shunsuke Nakano, Toshimitsu Ichijo, International Molecular Medicine Tri-Conference. . 2016

机译：ER阳性乳腺癌内分泌治疗抗ESR1突变的单管筛选
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy [O] . Tomás Reinert, Susana Ramalho, Vivian Castro Antunes de Vasconcelos, 2020

机译：ESR1突变不是新辅助芳香化酶抑制剂治疗的雌激素受体阳性乳腺癌患者内分泌抵抗的常见机制。
7. ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy [O] . Tomás Reinert, Susana Ramalho, Vivian Castro Antunes de Vasconcelos, 2020

机译：ESR1突变不是用Neoadjuvant芳香酶抑制剂治疗治疗的雌激素受体阳性乳腺癌患者内分泌抗性的常见机制

Adipsin Is an ERα Target Gene that Leads to Endocrine Resistance in Breast Cancer with ESR1 Mutations

著录项

相似文献

相关主题

期刊订阅